The Pharma-Bio Serv Inc (OTCMKTS:PBSV) stock was trading within a range on Monday and it was perhaps not particularly surprising since there has been no news about the technology transfer and project management consulting firm for many weeks.
On Monday, PBSV stock jumped 0.40% at $1 with more than 20k shares, compared to its average volume of 10k shares. The stock has moved within a range of $1.0040 – 1.0500 after opening trade at $1.03.
The last time any news emerged about the company was back on September 14, 2021 when Pharma-Bio announced its financial results for the quarter as well as the nine month period that had concluded on July 31, 2021. The company announced at the time that in the three month period it managed to bring in revenues of $4,988,000 and in the nine month period, the revenues came in at $1,4518,000.
However, those figures reflected a significant year on year drop. In the three month period, the year on year drop was $1290,000 while the drop in the nine month period amounted to $2,021,000. In this context, it is also important to point out that the net income in the quarter stood at $2,275,000 and that reflected a year on year rise of as much as $1583,000. It was also announced at the time that Pharma-Bio was looking for projects in the Latin America and Europe, in addition to the continental United States.